Home > List All Publishers > Current Partnering

Current Partnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers. CurrentPartnering publish a series of reports, providing access to critical decision making and best practice intelligence from leaders in business development and licensing.
Best practice – reports providing insight into best practice and trends in partnering
Directories – detailed analysis of partnering interests and activity of companies worldwide
Contracts – obtain an insight and understanding of the terms acceptable to a potential partner
CurrentPartnering was established in 2007 by Wildwood Ventures Ltd to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in partnering activity within the biopharma sector.

List of reports from Current Partnering

Antibody Partnering Terms and Agreements 3/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. ... \| more... Search inside this report	$2,695.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd edition 11/1/2010 \| published by: Current Partnering ... analysis of how and why companies enter asset purchase deals. The focus of the report is on partnerships for business, product, technology and royalty assets where partners have entered an agreement to dispose of or ... \| more... Search inside this report	$2,695.00
Bankinfo-Ukraine-2008 Financial Data Report 6/17/2010 \| published by: Current Partnering ... banks, securities companies and others. We provide more than 3 year financial information of these banks, such as: major business income growth ratio, total profit growth ratio, per capita income, Sales profit margin, assets-liability ratio. \| more... Search inside this report	$480.00
Bigpharma Partnering Agreements 3/1/2008 \| published by: Current Partnering ... into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail ... \| more... Search inside this report	$2,395.00
Bioinformatics Partnering Terms and Agreements 1/1/2011 \| published by: Current Partnering ... analysis of how and why companies enter bioinformatics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. ... \| more... Search inside this report	$2,695.00
Biomarker Partnering Terms and Agreements 4/1/2011 \| published by: Current Partnering ... analysis of how and why companies enter biomarker partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors biomarker technology. ... \| more... Search inside this report	$2,695.00
Biomarker Partnering Terms and Agreements 2/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter biomarker partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors biomarker technology. ... \| more... Search inside this report	$2,695.00
Cancer Vaccine Partnering Agreements 3/1/2012 \| published by: Current Partnering ... how and why companies enter cancer vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These ... \| more... Search inside this report	$1,695.00
Cardiovascular Partnering Terms and Agreements 3/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cardiovascular technology. ... \| more... Search inside this report	$2,695.00
Clinical Stage Partnering Agreements in Biopharma 6/1/2008 \| published by: Current Partnering ... of how and why companies enter clinical stage partnering deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to ... \| more... Search inside this report	$2,595.00
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2nd Edition 4/10/2010 \| published by: Current Partnering ... detailed understand and analysis of how and why companies enter clinical stage partnering deals. In addition a review of deal terms including upfront, milestone and royalty rates is provided. Understanding the flexibility of a prospective ... \| more... Search inside this report	$2,695.00
Companion Diagnostics Partnering Terms and Agreements 2/1/2012 \| published by: Current Partnering ... and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ... \| more... Search inside this report	$2,695.00
Companion Diagnostics Partnering Terms and Agreements 4/1/2011 \| published by: Current Partnering ... understanding and analysis of how and why companies enter companion diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ... \| more... Search inside this report	$2,695.00
Co-promotion and Co-marketing Agreements in Biopharma 1/1/2008 \| published by: Current Partnering ... and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research ... \| more... Search inside this report	$2,395.00
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 4th Edition 10/1/2010 \| published by: Current Partnering ... This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2003 to ... \| more... Search inside this report	$2,495.00
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition 7/1/2011 \| published by: Current Partnering ... This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2005 to ... \| more... Search inside this report	$2,995.00
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 5/1/2012 \| published by: Current Partnering ... Revised and updated 6th edition, includes: Trends in co-promotion and co-marketing deals Co-promotion and co-marketing agreement structure Co-promotion and co-marketing contract documents Top co-promotion deals by value Top co-marketing deals by value Most active co-promotion ... \| more... Search inside this report	$2,695.00
Diagnostics Partnering Terms and Agreements 2/1/2012 \| published by: Current Partnering ... how and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. These ... \| more...	$2,695.00
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6/1/2010 \| published by: Current Partnering ... a detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The focus of the report is on partnerships for discovery technologies and discovery stage ... \| more... Search inside this report	$2,695.00
Distribution Agreements in Biopharma 4/1/2008 \| published by: Current Partnering ... and why companies enter distribution deals. The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration. There are also numerous pure distribution deals whereby ... \| more... Search inside this report	$2,395.00
Distribution partnering Terms & Agreements in Pharma, Biotech & Diagnostics, 3rd Edition 10/1/2010 \| published by: Current Partnering ... and analysis of how and why companies enter distribution deals.The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultantproduct of the research collaboration. There are also numerous pure distribution ... \| more... Search inside this report	$2,695.00
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech, 2nd edition 11/1/2010 \| published by: Current Partnering ... a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the ... \| more... Search inside this report	$2,695.00
M&A Yearbook 2012 1/1/2012 \| published by: Current Partnering ... gain insight into the partnering activities of the past year. The report allows you to view all the M&A deals announced worldwide. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an ... \| more... Search inside this report	$2,995.00
Manufacturing and Supply Agreements in Biopharma 4/1/2008 \| published by: Current Partnering ... analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect ... \| more... Search inside this report	$2,395.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 3rd edition 10/1/2010 \| published by: Current Partnering ... report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2003 to early ... \| more... Search inside this report	$2,695.00

< prev 1 2 3 4 next >